The use of tamoxifen to improve height potential in short pubertal boys.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 16322179.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A retrospective chart review of 7 pubertal boys who were treated with tamoxifen was conducted to determine the effects of this therapy on skeletal maturation and predicted adult height. Tamoxifen significantly decreased the rate of skeletal maturation and increased the predicted adult height without negative effects on sexual maturation. Additional evaluation of this therapy is now required to determine if the increase in predicted adult height results in a clinically significant increase in final adult height.
Medical subject headings
- Bone Density Conservation Agents
- Growth Disorders
- Tamoxifen